Annual D&A
$259.00 K
+$145.00 K+127.19%
31 December 2023
Summary:
Galera Therapeutics annual depreciation & amortization is currently $259.00 thousand, with the most recent change of +$145.00 thousand (+127.19%) on 31 December 2023. During the last 3 years, it has fallen by -$109.00 thousand (-29.62%). GRTX annual D&A is now -66.71% below its all-time high of $778.00 thousand, reached on 31 December 2021.GRTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$6000.00
-$3000.00-33.33%
30 June 2024
Summary:
Galera Therapeutics quarterly depreciation & amortization is currently $6000.00, with the most recent change of -$3000.00 (-33.33%) on 30 June 2024. Over the past year, it has dropped by -$6000.00 (-50.00%). GRTX quarterly D&A is now -98.71% below its all-time high of $464.00 thousand, reached on 31 December 2021.GRTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$242.00 K
-$6000.00-2.42%
30 June 2024
Summary:
Galera Therapeutics TTM depreciation & amortization is currently $242.00 thousand, with the most recent change of -$6000.00 (-2.42%) on 30 June 2024. Over the past year, it has increased by +$172.00 thousand (+245.71%). GRTX TTM D&A is now -68.89% below its all-time high of $778.00 thousand, reached on 31 December 2021.GRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +127.2% | -50.0% | +245.7% |
| 3 y3 years | -29.6% | -94.3% | -41.0% |
| 5 y5 years | +103.9% | -92.0% | +28.7% |
GRTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.7% | +127.2% | -98.7% | at low | -68.9% | +245.7% |
| 5 y | 5 years | -66.7% | +127.2% | -98.7% | at low | -68.9% | +245.7% |
| alltime | all time | -66.7% | +208.3% | -98.7% | at low | -68.9% | +426.1% |
Galera Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $6000.00(-33.3%) | $242.00 K(-2.4%) |
| Mar 2024 | - | $9000.00(-95.8%) | $248.00 K(-4.2%) |
| Dec 2023 | $259.00 K(+127.2%) | $215.00 K(+1691.7%) | $259.00 K(+270.0%) |
| Sept 2023 | - | $12.00 K(0.0%) | $70.00 K(-17.6%) |
| June 2023 | - | $12.00 K(-40.0%) | $85.00 K(-17.5%) |
| Mar 2023 | - | $20.00 K(-23.1%) | $103.00 K(-9.6%) |
| Dec 2022 | $114.00 K(-85.3%) | $26.00 K(-3.7%) | $114.00 K(-79.3%) |
| Sept 2022 | - | $27.00 K(-10.0%) | $552.00 K(-12.5%) |
| June 2022 | - | $30.00 K(-3.2%) | $631.00 K(-10.2%) |
| Mar 2022 | - | $31.00 K(-93.3%) | $703.00 K(-9.6%) |
| Dec 2021 | $778.00 K | $464.00 K(+337.7%) | $778.00 K(+89.8%) |
| Sept 2021 | - | $106.00 K(+3.9%) | $410.00 K(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $102.00 K(-3.8%) | $401.00 K(+1.8%) |
| Mar 2021 | - | $106.00 K(+10.4%) | $394.00 K(+7.1%) |
| Dec 2020 | $368.00 K(+37.8%) | $96.00 K(-1.0%) | $368.00 K(+4.8%) |
| Sept 2020 | - | $97.00 K(+2.1%) | $351.00 K(+6.7%) |
| June 2020 | - | $95.00 K(+18.8%) | $329.00 K(+9.3%) |
| Mar 2020 | - | $80.00 K(+1.3%) | $301.00 K(+12.7%) |
| Dec 2019 | $267.00 K(+110.2%) | $79.00 K(+5.3%) | $267.00 K(+42.0%) |
| Sept 2019 | - | $75.00 K(+11.9%) | $188.00 K(+66.4%) |
| June 2019 | - | $67.00 K(+45.7%) | $113.00 K(+145.7%) |
| Mar 2019 | - | $46.00 K | $46.00 K |
| Dec 2018 | $127.00 K(+51.2%) | - | - |
| Dec 2017 | $84.00 K | - | - |
FAQ
- What is Galera Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Galera Therapeutics?
- What is Galera Therapeutics annual D&A year-on-year change?
- What is Galera Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Galera Therapeutics?
- What is Galera Therapeutics quarterly D&A year-on-year change?
- What is Galera Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Galera Therapeutics?
- What is Galera Therapeutics TTM D&A year-on-year change?
What is Galera Therapeutics annual depreciation & amortization?
The current annual D&A of GRTX is $259.00 K
What is the all time high annual D&A for Galera Therapeutics?
Galera Therapeutics all-time high annual depreciation & amortization is $778.00 K
What is Galera Therapeutics annual D&A year-on-year change?
Over the past year, GRTX annual depreciation & amortization has changed by +$145.00 K (+127.19%)
What is Galera Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GRTX is $6000.00
What is the all time high quarterly D&A for Galera Therapeutics?
Galera Therapeutics all-time high quarterly depreciation & amortization is $464.00 K
What is Galera Therapeutics quarterly D&A year-on-year change?
Over the past year, GRTX quarterly depreciation & amortization has changed by -$6000.00 (-50.00%)
What is Galera Therapeutics TTM depreciation & amortization?
The current TTM D&A of GRTX is $242.00 K
What is the all time high TTM D&A for Galera Therapeutics?
Galera Therapeutics all-time high TTM depreciation & amortization is $778.00 K
What is Galera Therapeutics TTM D&A year-on-year change?
Over the past year, GRTX TTM depreciation & amortization has changed by +$172.00 K (+245.71%)